Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: Perfect control of hepatitis B virus replication and absence of mitochondrial toxicity

AIDS

Volumn 23, Issue 9, 2009, Pages 1069-1076

  Tateo, Mariagrazia ^a,b,c,f   Roque Afonso, Anne Marie ^a,b,c   Antonini, Teresa Maria ^a,b,c   Medja, Fadia ^c,d,e   Lombes, Anne ^c,d,e   Jardel, Claude ^c,d,e   Teicher, Elina ^a   Sebagh, Mylène ^a,b,c   Roche, Bruno ^a,b,c   Castaing, Denis ^a,b,c   Samuel, Didier ^a,b,c   Duclos Vallee, Jean Charles ^a,b,c  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f UNIVERSITY OF BARI   (Italy)

Author keywords

Coinfection; Hepatitis B virus; Hepatitis C virus; Hepatitis D virus; Human immunodeficiency virus; Liver transplantation; Mitochondrial toxicity

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELTA AGENT HEPATITIS; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER FAILURE; LIVER FUNCTION; LIVER GRAFT; LIVER MITOCHONDRION; LIVER TRANSPLANTATION; MALE; MITOCHONDRIAL TOXICITY; MIXED INFECTION; PRIORITY JOURNAL; RESPIRATORY CHAIN; SURVIVAL RATE; SURVIVAL TIME; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATITIS D, CHRONIC; HIV; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MITOCHONDRIAL DISEASES; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL RATE; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 67651154598     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832c2a37     Document Type: Article

References (21)

1. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006; 166:1632-1641.
2. Marcellin P, Pequignot F, Delarocque-Astagneau E, Zarski JP, Ganne N, Hillon P, etal. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol 2008; 48:200-207.
3. DiMartino V, Thevenot T, Colin JF, Boyer N, Martinot M, Degos F, etal. Influence of HIVinfection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology 2002; 123:1812-1822.
4. Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 2004; 18:2039-2045.
5. Brau N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol 2007; 47:527-537.
6. Schreibman I, Gaynor JJ, Jayaweera D, Pyrsopoulos N, Weppler D, Tzakis A, et al. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients. Transplantation 2007; 84:697-705.
7. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008; 8: 355-365.
8. Duclos-Vallee JC, Feray C, Sebagh M, Teicher E, Roque-Afonso AM, Roche B, et al. Liver transplantation in HIV-HCV and HIV-HBV coinfected patients: a large experience in a single centre. I Hepatol 2006; 44:S8.
9. Norris S, Taylor C, Muiesan P, Portmann BC, Knisely AS, Bowles M, et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl 2004; 10:1271-1278.
10. Fung J, Eghtesad B, Patel-Tom K, DeVera M, Chapman H, Ragni M. Liver transplantation in patients with HIV infection. Liver Transpl 2004; 10:S39-53.
11. Le Gal F, Gordien E, Affolabi D, Hanslik T, Alloui C, Deny P, Gau lt E. Quantification of hepatitis delta virus RN A in serum by consensus real-time PCR indicates different patterns of viro-logical response to interferon therapy in chronically infected patients. J Clin Microbiol 2005; 43:2363-2369.
12. Morice Y, Cantaloube JF, Beaucourt S, Barbotte L, De Gendt S, Goncales FL, et al. Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol 2006; 78:1296-1303.
13. Roche B, Feray C, Gigou M, Roque-Afonso AM, Arulnaden JL, Delvart V, et al. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immuno-prophylaxis. Hepatology 2003; 38:86-95.
14. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Pe-tersen J, Lau G, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipi-voxil therapy. Gastroenterology 2004; 126:1750-1758.
15. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25:658-663.
16. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, etal. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 2000; 31:792-799.
17. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24:289-293.
18. Duclos-Vallee JC, Vittecoq D, Teicher E, Feray C, Roque-Afonso AM, Lombes A, etal. Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients. J Hepatol 2005; 42:341-349.
19. Duclos-Vallee JC, Feray C, Sebagh M, Teicher E, Roque-Afonso AM, Roche B, et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008; 47:407-417.
20. Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl 2006; 12:801-807.
21. Faria LC, Gigou M, Roque-Afonso AM, Sebagh M, Roche B, Fallot G, et al. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. Gastroenterology 2008; 134:1890-1899; quiz 2155.